US FDA Adds New Faces To Vaccines Adcomm For Pfizer/BioNTech COVID-19 Review
Executive Summary
The Vaccines and Related Biological Products Advisory Committee will have five more members than were present for the 22 October meeting on coronavirus vaccine development and approval issues.